The Effects of Tiopronin on 3-Aminopropanal Level & Neurologic Outcome After Aneurysmal Subarachnoid Hemorrhage

Active, not recruiting

Phase 2 Results N/A

Summary of Purpose

The purpose of this phase II study is to further assess the safety of tiopronin in aneurysmal subarachnoid hemorrhage(aSAH) patients in order to obtain preliminary data on the efficacy of tiopronin versus placebo in reducing serum and CSF 3AP levels in this patient population.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 August 2012.

1 Apr 2010 25 Mar 2010 1 Jul 2012 1 Jul 2013 1 Aug 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions See All

Conditions

Sponsors See All

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Bio-availability Study
  • Intervention: Parallel Assignment

Contacts